Martin Shkreli (seen in August 2017) is pleading for a substantial reduction in his possible sentence, saying he will be ‘more honest’ in the future. Shkreli, infamous for increasing the cost of drug Daraprim by 5,000 per cent, has been found guilty of securities fraud. File photo: Reuters

Martin Shkreli (seen in August 2017) is pleading for a substantial reduction in his possible sentence, saying he will be ‘more honest’ in the future. Shkreli, infamous for increasing the cost of drug Daraprim by 5,000 per cent, has been found guilty of securities fraud. File photo: Reuters